RT Journal Article SR Electronic T1 GP IIb/IIIa inhibitors in coronary artery disease management: What the latest trials tell us JF Cleveland Clinic Journal of Medicine JO Cleve Clin J Med FD Cleveland Clinic SP 1017 OP 1023 VO 68 IS 12 A1 Chew, Derek P. A1 Moliterno, David J. YR 2001 UL http://www.ccjm.org/content/68/12/1017.abstract AB Recent clinical trials have refined our understanding of how the glycoprotein (GP) IIb/IIIa inhibitors should best be used. These trials examined whether there are clinical differences between agents, whether empiric use of GP IIb/IIIa inhibitors in acute coronary syndromes is justified, and whether these drugs might allow for early invasive management in acute coronary syndromes.